Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Non-cash Items (2016 - 2018)

Tandem Diabetes Care (TNDM) has disclosed Non-cash Items for 6 consecutive years, with $117.0 million as the latest value for Q4 2018.

  • For the quarter ending Q4 2018, Non-cash Items rose 19312.39% year-over-year to $117.0 million, compared with a TTM value of $117.0 million through Dec 2018, up 19312.39%, and an annual FY2018 reading of $117.0 million, up 19312.39% over the prior year.
  • Non-cash Items was $117.0 million for Q4 2018 at Tandem Diabetes Care, up from $602646.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $117.0 million in Q4 2018 and bottomed at $602646.0 in Q4 2017.
  • Average Non-cash Items over 5 years is $32.4 million, with a median of $19.2 million recorded in 2015.
  • The sharpest move saw Non-cash Items crashed 91.68% in 2016, then surged 19312.39% in 2018.
  • Year by year, Non-cash Items stood at $23.5 million in 2014, then decreased by 18.59% to $19.2 million in 2015, then plummeted by 91.68% to $1.6 million in 2016, then crashed by 62.17% to $602646.0 in 2017, then soared by 19312.39% to $117.0 million in 2018.
  • Business Quant data shows Non-cash Items for TNDM at $117.0 million in Q4 2018, $602646.0 in Q4 2017, and $1.6 million in Q4 2016.